Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
3
×
boston blog main
boston top stories
crispr
3
×
editas medicine
3
×
life sciences
national blog main
allergan
clinical trials
cynthia collins
gene editing
abbvie
alzheimer's disease
beam therapeutics
biotech week boston
bristol-myers squibb
broad institute
bwb
cancer
cindy perettie
david liu
deals
drugs
foundation medicine
immuno-oncology
katrine bosley
laurie glimcher
leber congenital amaurosis
leber congenital amaurosis type 10
luk vandenberghe
mass eye and ear
michelle robertson
national top stories
new york blog main
oncology
parkinson's disease
precision medicine
rare diseases
san francisco blog main
What
editas
editing
experimental
gene
medicine
abbvie
allergan
alliance
benefiting
biotech
blessing
bosley
boston
ceo
check
clinical
coming
crispr
cusp
depart
diagnostics
exits
genetic
glimcher
groundbreaking
headline
humans
katrine
keynote
laurie
market
medicines
million
pact
partner
partnership
patients
precision
promise
pruning
Language
unset
Current search:
crispr
×
boston
×
" editas medicine "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
5 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial